Analyzing treatment options for brain hemorrhage

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate how early hematoma morphology affects hematoma expansion in patients with cerebral hemorrhage. By analyzing clinical data and imaging results, the study seeks to optimize treatment plans and improve patient outcomes. It will explore the effectiveness of various surgical interventions, including stereotactic hematoma puncture, decompressive craniectomy, and neuroendoscopic techniques. The goal is to provide insights that can guide clinical practice in managing this serious condition.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Age 18-80 years old;
2. Intracerebral hemorrhage was diagnosed by head CT examination;

Exclusion Criteria:

1. Multiple intracranial hemorrhage;
2. Intracranial hemorrhage caused by intracranial tumor, aneurysm, trauma, infarction or other lesions;
3. Coagulation disorders or a history of taking anticoagulants;
4. Infectious meningitis, systemic infection;
5. History of severe stroke, heart, kidney, liver and lung dysfunction in the past;
6. Severe brain herniation (mydriasis, respiratory and circulatory failure);
7. Incomplete or missing basic data or follow-up information in the hospital.

Where it's running

• Guizhou Medical University Affiliated Hospital
  Guiyang, Guizhou, China Recruiting

Study contacts

• Study coordinator: Wu guofeng, Doctor
• Phone: 13809431723

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry of stroke cases in Brest

  This study is collecting information on stroke cases in Brest to see how common strokes are, understand their impact on patients, and find better ways to treat them.

  Recruiting University Hospital, Brest · Brest · NCT02900521

• Oral paclitaxel with anti-HER2 therapy in HER2-positive breast cancer before surgery

  This trial tests a paclitaxel oral solution given with trastuzumab and pertuzumab to see if a safe dose can be found for women with HER2-positive breast cancer before they have surgery.

  Recruiting Phase 1/2 The Affiliated Hospital Of Guizhou Medical University · Guiyang, Guizhou · NCT07739511

• Oral paclitaxel in triple-negative breast cancer before main chemotherapy

  This trial tests whether giving an oral paclitaxel dose-6 in combination with standard epirubicin and cyclophosphamide can be tolerated in women with triple-negative breast cancer before surgery.

  Recruiting Phase 1/2 The Affiliated Hospital Of Guizhou Medical University · Guiyang, Guizhou · NCT07739485

• Individualized mRNA cancer vaccine for advanced solid tumors

  This study is testing a personalized mRNA cancer vaccine to see if it can help people with advanced solid tumors feel better when combined with another treatment.

  Recruiting Early Phase 1 The Affiliated Hospital Of Guizhou Medical University · Guiyang, China/Guizhou · NCT06497010

• Using intrathecal nicardipine to treat vasospasm after aneurysmal subarachnoid hemorrhage

  This study is testing if giving nicardipine directly into the spine can help patients with vasospasm after a brain bleed feel better compared to regular treatment.

  Recruiting at 28 sites The Affiliated Hospital Of Guizhou Medical University · Hefei, Anhui and 27 other locations · NCT06329635

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.